Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for Brain Bleeding After Head Trauma

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, Aug. 5, 2025 -- Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older adults, according to a study published in the October issue of the American Journal of Emergency Medicine.

Chelsea Caplan, from the University of Miami Miller School of Medicine, and colleagues assessed whether a supratherapeutic INR (INR >3.0) is associated with an increased risk for intracranial hemorrhage (ICH) in geriatric patients prescribed preinjury warfarin who presented to the emergency department following head trauma. The evaluation involved a secondary analysis of a prospective study and included 2,686 patients, of whom 2,423 were in the no-anticoagulants or antiplatelet group and 263 were in the warfarin group.

The researchers found that about 11 percent of the patients experienced brain bleeding after head trauma. Among patients not on blood thinners, about 6 percent had brain bleeds versus approximately 7 percent of patients on warfarin. For INR levels above and below 3.0, ICH rates were similar. In a post hoc analysis of ICH rates by INR, patients with subtherapeutic INR levels (INR <2.0) had the highest rates of brain bleeding -- nearly 20 percent -- while those within or above the therapeutic range (INR 2.0 to 4.9) had lower rates. No brain bleeds occurred in patients with critically high INR levels (INR ≥5.0).

"Data from our study suggest supratherapeutic INR levels may not increase intracranial hemorrhage risk as much as we previously believed," senior author Richard Shih, M.D., from the Charles E. Schmidt College of Medicine at Florida Atlantic University in Boca Raton, said in a statement. "It's critical to re-examine our approach to managing anticoagulation in older adults after head trauma to provide the safest, most effective care without unnecessary tests or hospital stays."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-06 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords